Deutsche Bank Cuts Novozymes B Target Price but Maintains ‘Buy’ Rating Amid Sector Uncertainty
Novozymes B’s shares have been adjusted to a target price of 480 Danish kroner by Deutsche Bank, despite a “buy” recommendation, due to concerns over a potential downturn in the chemical industry and uncertainty in demand projections.
4 minutes to read